RGS 0.00% 12.0¢ regeneus ltd

novel canine cancer vaccine gets green light, page-13

  1. 5,372 Posts.
    Hi Ben,

    It tipped RGS, does not provide a target.

    Given its record with BLT and a biotech company in US (Organovo), it probably aiming for triple digits return.

    Comparing to Mesoblast, RGS is an interesting company.

    Short term holders/traders might look for quick monies on this.

    Long term, $1 or more!!
 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.